Twist Bioscience Corporation (TWST)
NASDAQ · Healthcare
Twist Bioscience Corporation Operating Income 2017–2025
Twist Bioscience Corporation annual/quarterly operating income history and growth rate from 2017 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Twist Bioscience Corporation operating income for the quarter ending March 31, 2026 was -45.9 M, a 10.35% increase year-over-year.
- Twist Bioscience Corporation operating income for the twelve months ending March 31, 2026 was -150.4 M, a 31.44% decrease year-over-year.
- Twist Bioscience Corporation annual operating income for 2025 was -136.3 M, a 38.30% decrease from 2024.
- Twist Bioscience Corporation annual operating income for 2024 was -220.8 M, a 1.69% increase from 2023.
- Twist Bioscience Corporation annual operating income for 2023 was -217.2 M, a 7.50% decrease from 2022.
- Twist Bioscience Corporation annual operating income for 2022 was -234.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Twist Bioscience Corporation Operating Income — FAQ
Twist Bioscience Corporation (TWST) operating income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Twist Bioscience Corporation's operating income?
Twist Bioscience Corporation (TWST) reported operating income of -$136M for fiscal 2025.
Where can I see TWST's operating income history?
The chart and table above show Twist Bioscience Corporation's operating income by year and by quarter, including the growth rate.